These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 17085665

  • 1. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Cancer Res; 2006 Nov 01; 12(21):6502-8. PubMed ID: 17085665
    [Abstract] [Full Text] [Related]

  • 2. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov 01; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC.
    Gynecol Oncol; 2006 Dec 01; 103(3):1063-9. PubMed ID: 16875719
    [Abstract] [Full Text] [Related]

  • 4. Estimation of glomerular filtration rate in cancer patients.
    Wright JG, Boddy AV, Highley M, Fenwick J, McGill A, Calvert AH.
    Br J Cancer; 2001 Feb 01; 84(4):452-9. PubMed ID: 11207037
    [Abstract] [Full Text] [Related]

  • 5. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
    Ekhart C, Rodenhuis S, Schellens JH, Beijnen JH, Huitema AD.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):115-22. PubMed ID: 18989671
    [Abstract] [Full Text] [Related]

  • 6. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 Jun 01; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K, Lipp HP, Beijnen JH, Bokemeyer C, Hartmann JT.
    Cancer Chemother Pharmacol; 2011 Sep 01; 68(3):693-701. PubMed ID: 21136060
    [Abstract] [Full Text] [Related]

  • 8. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD, Mathôt RA, Tibben MM, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Pharmacol Ther; 2000 Jun 01; 67(6):621-30. PubMed ID: 10872644
    [Abstract] [Full Text] [Related]

  • 9. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST, Gillen G, Morrison P, Forte C, Macpherson IR, White JD, Mark PB.
    Eur J Cancer; 2014 Mar 01; 50(5):944-52. PubMed ID: 24445148
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K, Gervais A, Aikin A, Egorin M, Balis FM.
    Cancer Chemother Pharmacol; 2004 Sep 01; 54(3):206-12. PubMed ID: 15156345
    [Abstract] [Full Text] [Related]

  • 11. [Serum creatinine and creatinine clearance to estimate renal function in essential hypertension].
    Jabary NS, Martín D, Muñoz MF, Santos M, Herruzo J, Gordillo R, Bustamante J.
    Nefrologia; 2006 Sep 01; 26(1):64-73. PubMed ID: 16649427
    [Abstract] [Full Text] [Related]

  • 12. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
    Schmitt A, Gladieff L, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Serre-Debauvais F, Pinguet F, Floquet A, Billaud E, Le Guellec C, Penel N, Campone M, Largillier R, Capitain O, Fabbro M, Houede N, Medioni J, Bougnoux P, Lochon I, Chatelut E.
    Clin Cancer Res; 2009 May 15; 15(10):3633-9. PubMed ID: 19401344
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose.
    Shord SS, Bressler LR, Radhakrishnan L, Chen N, Villano JL.
    Ann Pharmacother; 2009 Feb 15; 43(2):235-41. PubMed ID: 19193580
    [Abstract] [Full Text] [Related]

  • 14. Novel algorithm for more accurate calculation of renal function in adults with cancer.
    Holweger K, Lipp HP, Dietz K, Hartmann JT, Bokemeyer C.
    Ann Pharmacother; 2008 Dec 15; 42(12):1749-57. PubMed ID: 19033483
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
    Shen M, Schilder RJ, Obasaju C, Gallo JM.
    Cancer Chemother Pharmacol; 2002 Sep 15; 50(3):243-50. PubMed ID: 12203107
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of high-dose carboplatin in children and adults.
    Lindauer A, Eickhoff C, Kloft C, Jaehde U.
    Ther Drug Monit; 2010 Apr 15; 32(2):159-68. PubMed ID: 20110851
    [Abstract] [Full Text] [Related]

  • 17. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May 15; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 18. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD, Tran HT, Riggs MW.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(2):241-7. PubMed ID: 16133538
    [Abstract] [Full Text] [Related]

  • 19. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
    Tidman M, Sjöström P, Jones I.
    Nephrol Dial Transplant; 2008 Jan 15; 23(1):154-60. PubMed ID: 17911090
    [Abstract] [Full Text] [Related]

  • 20. What is the most appropriate formula to use in estimating glomerular filtration rate in adult Arabs without kidney disease?
    Al-Khader AA, Tamim H, Sulaiman MH, Jondeby MS, Taher S, Hejaili FF, Ghamdi G, Flaiw A, Hakami A.
    Ren Fail; 2008 Jan 15; 30(2):205-8. PubMed ID: 18300122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.